{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:45:55Z","timestamp":1788281155486,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1245\/s10434-025-18981-4","type":"journal-article","created":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T19:19:06Z","timestamp":1768936746000},"page":"4795-4805","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Intratumoral and Peritumoral Fat CT\u2011Based Radiomics for Predicting Recurrence Risk in Non-Muscle-Invasive Bladder Cancer: A Two-Center Study"],"prefix":"10.1245","volume":"33","author":[{"given":"Meng","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hehe","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bitian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,20]]},"reference":[{"key":"18981_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41585-024-00914-7","volume":"22","author":"M Olislagers","year":"2025","unstructured":"Olislagers M, de Jong FC, Rutten VC, Boormans JL, Mahmoudi T, Zuiverloon TCM. Molecular biomarkers of progression in non-muscle-invasive bladder cancer: beyond conventional risk stratification. Nat Rev Urol. 2025;22:75-91.\u00a0https:\/\/doi.org\/10.1038\/s41585-024-00914-7.","journal-title":"Nat Rev Urol."},{"key":"18981_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/s1040-8428(01)00128-7","volume":"41","author":"F de Braud","year":"2002","unstructured":"de Braud F, Maffezzini M, Vitale V, et al. Bladder cancer. Crit Rev Oncol Hematol. 2002;41:89-106. https:\/\/doi.org\/10.1016\/s1040-8428(01)00128-7.","journal-title":"Crit Rev Oncol Hematol."},{"key":"18981_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3322\/caac.21763","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics CA Cancer J Clin. 2023;73:17-48. https:\/\/doi.org\/10.3322\/caac.21763.","journal-title":"CA Cancer J Clin."},{"key":"18981_CR4","doi-asserted-by":"publisher","first-page":"e076743","DOI":"10.1136\/bmj-2023-076743","volume":"384","author":"A Lopez-Beltran","year":"2024","unstructured":"Lopez-Beltran A, Cookson MS, Guercio BJ, Cheng L. Advances in diagnosis and treatment of bladder cancer. BMJ. 2024;384:e076743. https:\/\/doi.org\/10.1136\/bmj-2023-076743.","journal-title":"BMJ."},{"key":"18981_CR5","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1038\/nrurol.2015.12","volume":"12","author":"A Sanchez","year":"2015","unstructured":"Sanchez A, Wszolek MF. Bladder cancer: quality of life in patients with non-muscle-invasive bladder cancer. Nat Rev Urol. 2015;12:186-188. https:\/\/doi.org\/10.1038\/nrurol.2015.12.","journal-title":"Nat Rev Urol."},{"key":"18981_CR6","doi-asserted-by":"publisher","first-page":"5019","DOI":"10.3390\/cancers14205019","volume":"14","author":"AT Shalata","year":"2022","unstructured":"Shalata AT, Shehata M, Van Bogaert E, et al. Predicting recurrence of non-muscle-invasive bladder cancer: current techniques and future trends. Cancers (Basel). 2022;14:5019. https:\/\/doi.org\/10.3390\/cancers14205019.","journal-title":"Cancers Basel."},{"key":"18981_CR7","doi-asserted-by":"publisher","first-page":"116312","DOI":"10.1016\/j.biopha.2024.116312","volume":"173","author":"J Fan","year":"2024","unstructured":"Fan J, Chen B, Luo Q, et al. Potential molecular biomarkers for the diagnosis and prognosis of bladder cancer. Biomed Pharmacother. 2024;173:116312. https:\/\/doi.org\/10.1016\/j.biopha.2024.116312.","journal-title":"Biomed Pharmacother."},{"key":"18981_CR8","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1097\/js9.0000000000000859","volume":"110","author":"SW Kim","year":"2024","unstructured":"Kim SW, Yu H, Kim Y, et al. HER2 overexpression predicts pathological T2 stage and improved survival in de novo muscle-invasive bladder cancer after immediate radical cystectomy: a retrospective cohort study. Int J Surg. 2024;110:847-858. https:\/\/doi.org\/10.1097\/js9.0000000000000859.","journal-title":"Int J Surg."},{"key":"18981_CR9","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.3390\/ijms22062800","volume":"22","author":"FC de Jong","year":"2021","unstructured":"de Jong FC, Rutten VC, Zuiverloon TCM, Theodorescu D. Improving anti-PD-1\/PD-L1 therapy for localized bladder cancer. Int J Mol Sci. 2021;22:2800. https:\/\/doi.org\/10.3390\/ijms22062800.","journal-title":"Int J Mol Sci."},{"key":"18981_CR10","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1158\/1535-7163.Mct-14-0983","volume":"14","author":"SP Patel","year":"2015","unstructured":"Patel SP, Kurzrock R. PD-L1 Expression as a predictive biomarker in cancer immunotherapy. Mol Cancer Ther. 2015;14:847-856. https:\/\/doi.org\/10.1158\/1535-7163.Mct-14-0983.","journal-title":"Mol Cancer Ther."},{"key":"18981_CR11","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1007\/s11912-025-01645-7","volume":"27","author":"S Smani","year":"2025","unstructured":"Smani S, DuBois J, Zhao K, et al. Advancements in the diagnosis, treatment, and risk stratification of non-muscle invasive bladder cancer. Curr Oncol Rep. 2025;27:236-246. https:\/\/doi.org\/10.1007\/s11912-025-01645-7.","journal-title":"Curr Oncol Rep."},{"key":"18981_CR12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s11912-021-01091-1","volume":"23","author":"H Slovacek","year":"2021","unstructured":"Slovacek H, Zhuo J, Taylor JM. Approaches to non-muscle-invasive bladder cancer. Curr Oncol Rep. 2021;23:105. https:\/\/doi.org\/10.1007\/s11912-021-01091-1.","journal-title":"Curr Oncol Rep."},{"key":"18981_CR13","doi-asserted-by":"publisher","first-page":"488","DOI":"10.2967\/jnumed.118.222893","volume":"61","author":"ME Mayerhoefer","year":"2020","unstructured":"Mayerhoefer ME, Materka A, Langs G, et al. Introduction to radiomics. J Nucl Med. 2020;61:488-495. https:\/\/doi.org\/10.2967\/jnumed.118.222893.","journal-title":"J Nucl Med."},{"key":"18981_CR14","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s13244-024-01662-3","volume":"15","author":"G Yang","year":"2024","unstructured":"Yang G, Bai J, Hao M, Zhang L, Fan Z, Wang X. Enhancing recurrence risk prediction for bladder cancer using multi-sequence MRI radiomics. Insights Imaging. 2024;15:88. https:\/\/doi.org\/10.1186\/s13244-024-01662-3.","journal-title":"Insights Imaging."},{"key":"18981_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13244-023-01569-5","volume":"15","author":"R Sun","year":"2024","unstructured":"Sun R, Zhang M, Yang L, et al. Preoperative CT-based deep learning radiomics model to predict lymph node metastasis and patient prognosis in bladder cancer: a two-center study. Insights Imaging. 2024;15:21. https:\/\/doi.org\/10.1186\/s13244-023-01569-5.","journal-title":"Insights Imaging."},{"key":"18981_CR16","doi-asserted-by":"publisher","first-page":"6173","DOI":"10.1245\/s10434-025-17228-6","volume":"32","author":"X Yang","year":"2025","unstructured":"Yang X, Yang R, Liu X, Chen Z, Zheng Q. Recent advances in artificial intelligence for precision diagnosis and treatment of bladder cancer: a review. Ann Surg Oncol. 2025;32:6173-6184. https:\/\/doi.org\/10.1245\/s10434-025-17228-6.","journal-title":"Ann Surg Oncol."},{"key":"18981_CR17","doi-asserted-by":"publisher","first-page":"188984","DOI":"10.1016\/j.bbcan.2023.188984","volume":"1878","author":"S Goswami","year":"2023","unstructured":"Goswami S, Zhang Q, Celik CE, Reich EM, Yilmaz \u00d6H. Dietary fat and lipid metabolism in the tumor microenvironment. Biochim Biophys Acta Rev Cancer. 2023;1878:188984. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188984.","journal-title":"Biochim Biophys Acta Rev Cancer."},{"key":"18981_CR18","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.Can-10-3323","volume":"71","author":"B Dirat","year":"2011","unstructured":"Dirat B, Bochet L, Dabek M, et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 2011;71:2455-2465. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-3323.","journal-title":"Cancer Res."},{"key":"18981_CR19","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-022-02408-z","volume":"41","author":"X Zhou","year":"2022","unstructured":"Zhou X, Zhang J, Lv W, et al. The pleiotropic roles of adipocyte secretome in remodeling breast cancer. J Exp Clin Cancer Res. 2022;41:203. https:\/\/doi.org\/10.1186\/s13046-022-02408-z.","journal-title":"J Exp Clin Cancer Res."},{"key":"18981_CR20","doi-asserted-by":"publisher","first-page":"217271","DOI":"10.1016\/j.canlet.2024.217271","volume":"604","author":"L Yu","year":"2024","unstructured":"Yu L, Wei W, Lv J, Lu Y, Wang Z, Cai C. FABP4-mediated lipid metabolism promotes TNBC progression and breast cancer stem cell activity. Cancer Lett. 2024;604:217271. https:\/\/doi.org\/10.1016\/j.canlet.2024.217271.","journal-title":"Cancer Lett."},{"key":"18981_CR21","doi-asserted-by":"publisher","first-page":"3925","DOI":"10.7150\/thno.82911","volume":"13","author":"YC Lin","year":"2023","unstructured":"Lin YC, Hou YC, Wang HC, Shan YS. New insights into the role of adipocytes in pancreatic cancer progression: paving the way towards novel therapeutic targets. Theranostics. 2023;13:3925-3942. https:\/\/doi.org\/10.7150\/thno.82911.","journal-title":"Theranostics."},{"key":"18981_CR22","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1186\/s12964-023-01294-y","volume":"21","author":"A Alvarez-Artime","year":"2023","unstructured":"Alvarez-Artime A, Garcia-Soler B, Gonzalez-Menendez P, et al. Castration promotes the browning of the prostate tumor microenvironment. Cell Commun Signal. 2023;21:267. https:\/\/doi.org\/10.1186\/s12964-023-01294-y.","journal-title":"Cell Commun Signal."},{"key":"18981_CR23","doi-asserted-by":"publisher","first-page":"e422","DOI":"10.1016\/j.clgc.2023.05.005","volume":"21","author":"J Lu","year":"2023","unstructured":"Lu J, Li X, Chen M, et al. Perivesical fat invasive pattern as prognostic factor and predictor of response to adjuvant chemotherapy in T3-stage bladder cancer. Clin Genitourin Cancer. 2023;21:e422-e428. https:\/\/doi.org\/10.1016\/j.clgc.2023.05.005.","journal-title":"Clin Genitourin Cancer."},{"key":"18981_CR24","doi-asserted-by":"publisher","first-page":"102199","DOI":"10.1016\/j.clgc.2024.102199","volume":"22","author":"N Yu","year":"2024","unstructured":"Yu N, Xu C, Jiang Y, et al. Characteristics of abdominal fat based on CT measurements to predict early recurrence after initial surgery of NMIBC in stage Ta\/T1. Clin Genitourin Cancer. 2024;22:102199. https:\/\/doi.org\/10.1016\/j.clgc.2024.102199.","journal-title":"Clin Genitourin Cancer."},{"key":"18981_CR25","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD. Bladder cancer: a review. JAMA. 2020;324:1980-1991. https:\/\/doi.org\/10.1001\/jama.2020.17598.","journal-title":"JAMA."},{"key":"18981_CR26","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.cmet.2021.01.018","volume":"33","author":"OA Maguire","year":"2021","unstructured":"Maguire OA, Ackerman SE, Szwed SK, et al. Creatine-mediated crosstalk between adipocytes and cancer cells regulates obesity-driven breast cancer. Cell Metab. 2021;33:499-512. https:\/\/doi.org\/10.1016\/j.cmet.2021.01.018.","journal-title":"Cell Metab."},{"key":"18981_CR27","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s12964-018-0309-z","volume":"16","author":"JY He","year":"2018","unstructured":"He JY, Wei XH, Li SJ, et al. Adipocyte-derived IL-6 and leptin promote breast cancer metastasis via upregulation of lysyl hydroxylase-2 expression. Cell Commun Signal. 2018;16:100. https:\/\/doi.org\/10.1186\/s12964-018-0309-z.","journal-title":"Cell Commun Signal."},{"key":"18981_CR28","doi-asserted-by":"publisher","first-page":"112332","DOI":"10.1016\/j.intimp.2024.112332","volume":"136","author":"H Xie","year":"2024","unstructured":"Xie H, Ruan G, Wei L, et al. Obesity-associated metabolic inflammation promotes triple-negative breast cancer progression through the interleukin-6\/STAT3\/pentraxin 3\/matrix metalloproteinase 7 axis. Int Immunopharmacol. 2024;136:112332. https:\/\/doi.org\/10.1016\/j.intimp.2024.112332.","journal-title":"Int Immunopharmacol."},{"key":"18981_CR29","doi-asserted-by":"publisher","first-page":"5792","DOI":"10.1016\/j.clnu.2021.10.019","volume":"40","author":"ZB Ke","year":"2021","unstructured":"Ke ZB, Chen H, Chen JY, et al. Preoperative abdominal fat distribution and systemic immune inflammation were associated with response to intravesical Bacillus Calmette-Guerin immunotherapy in patients with non-muscle invasive bladder cancer. Clin Nutr. 2021;40:5792-5801. https:\/\/doi.org\/10.1016\/j.clnu.2021.10.019.","journal-title":"Clin Nutr."},{"key":"18981_CR30","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1097\/js9.0000000000001358","volume":"110","author":"S Li","year":"2024","unstructured":"Li S, Zhou Z, Gao M, et al. Incremental value of automatically segmented perirenal adipose tissue for pathological grading of clear cell renal cell carcinoma: a multicenter cohort study. Int J Surg. 2024;110:4221-4230. https:\/\/doi.org\/10.1097\/js9.0000000000001358.","journal-title":"Int J Surg."},{"key":"18981_CR31","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1007\/s00261-024-04265-0","volume":"49","author":"J Xue","year":"2024","unstructured":"Xue J, Zhuang Z, Peng L, et al. Prognostic predictive value of urothelial carcinoma of the bladder after TURBT based on multiphase CT radiomics. Abdom Radiol NY. 2024;49:1975-1986. https:\/\/doi.org\/10.1007\/s00261-024-04265-0.","journal-title":"Abdom Radiol NY."},{"key":"18981_CR32","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1002\/jmri.26749","volume":"50","author":"X Xu","year":"2019","unstructured":"Xu X, Wang H, Du P, et al. A predictive nomogram for individualized recurrence stratification of bladder cancer using multiparametric MRI and clinical risk factors. J Magn Reson Imaging. 2019;50:1893-1904. https:\/\/doi.org\/10.1002\/jmri.26749.","journal-title":"J Magn Reson Imaging."},{"key":"18981_CR33","doi-asserted-by":"publisher","first-page":"2438291","DOI":"10.1080\/2162402x.2024.2438291","volume":"14","author":"CG Ca\u00f1izo","year":"2025","unstructured":"Ca\u00f1izo CG, Guerrero-Ramos F, Perez Escavy M, et al. Characterisation of the tumour microenvironment and PD-L1 granularity reveals the prognostic value of cancer-associated myofibroblasts in non-invasive bladder cancer. Oncoimmunology. 2025;14:2438291. https:\/\/doi.org\/10.1080\/2162402x.2024.2438291.","journal-title":"Oncoimmunology."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-025-18981-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-025-18981-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T12:27:35Z","timestamp":1776256055000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-025-18981-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,20]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["18981"],"URL":"https:\/\/doi.org\/10.1245\/s10434-025-18981-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,20]]},"assertion":[{"value":"12 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"There are no conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}